Found 9 matching trials
A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.
PHASE1This is a randomized, double-blind, dose-escalating, placebo-controlled pha...
Location
The First Bethune Hospital of Jilin University
Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata
PHASE2This study is a multicenter, randomized, double-blind, placebo-controlled P...
Location
The Peking University People's Hospital, Beijing, Beijng
Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects
PHASE1This clinical trial is a randomized, double-blind, single-center, placebo-c...
Location
The First Hospital of Jilin University
Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
PHASE3This clinical trial is a multicenter, randomized, double-blind, controlled ...
Location
Chinese Academy of Medical Sciences Hospital for Skin Diseases
Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
PHASE3This clinical trial is a multicenter, randomized, double-blind, controlled ...
Location
Peking University People's Hospital
Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
PHASE2This clinical trial is a multicenter, randomized, double-blind, controlled ...
Location
Peking University People's Hospital
Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
PHASE2This clinical trial is a multicenter, randomized, double-blind, controlled ...
Location
Chinese Academy of Medical Sciences Hospital for Skin Diseases
Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects
PHASE1This clinical trial consists of two partsοΌ1. a randomized, double-blind, si...
Location
The First Hospital of Jilin University
Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo
PHASE2This clinical trial is a multicenter, randomized, double-blind, controlled ...
Location
The Peking University People's Hospital